Imaging bloodbrain barrier disruption in neuroinflammation and Alzheimer's disease
It correlates with ischemia duration and, importantly, occurs alongside hyperperfusion in this swine model of recanalized AIS, showing that IMR and hyperperfusion can co-exist

BPC-157/TB-500/KPV/GHK-Cu 10+10+10+50mg (KLOW blend 80mg) $225.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC+TB500+GHK-Cu+KPV SYNONYMS KLOW blend CAS NUMBER 137525-51-0 (BPC-157), 77591-33-4 (TB500), 300801-03-0 (GHK-Cu), 2828433-34-5 (KPV) MOLECULAR FORMULA C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu), C 18 H 34 N 4 O 6 (KPV) MOLECULAR WEIGHT ~7189 g/mol STRUCTURE Multi-peptide blend PEPTIDE SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (BPC-157), Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (TB500), Gly-His-Lys (GHK-Cu), Lys-Pro-Val (KPV) CHEMICAL STRUCTURE Molecular Formula : C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu), C 18 H 34 N 4 O 6 (KPV) Source: PubChem Mechanism of Action The KLOW blend acts on multiple cellular pathways that regulate inflammation, tissue repair, angiogenesis, and oxidative balance

J Computat Chem